Cleo Whiting, Sara Abdel Azim, Nicolas Joly-Tonetti, Nadege Lachmann, Adam Friedman
{"title":"含有胶体燕麦和 Filaggrin 技术的保湿霜对葡萄球菌体外培养的影响","authors":"Cleo Whiting, Sara Abdel Azim, Nicolas Joly-Tonetti, Nadege Lachmann, Adam Friedman","doi":"10.36849/JDD.8706","DOIUrl":null,"url":null,"abstract":"<p><p>The pathophysiology of atopic dermatitis (AD) is multifactorial, with genetic predisposition, environmental exposures, and dysbiosis of the skin microbiome all associated with disease activity. Colonization by Staphylococcus aureus (S. aureus) is specifically associated with AD, and modifying the skin microbiota through topical skincare products may play a role in AD management. A moisturizer containing colloidal oatmeal, a patented filaggrin technology, niacinamide, and tocopheryl acetate was assessed for its impact on the growth, biofilm formation, and bacterial mix adhesion of S. aureus and/or S. epidermidis on reconstructed human epidermis (RHE). Compared to control conditions, the bacterial growth and adhesion of S. aureus were decreased compared to S. epidermidis in the presence of the moisturizer. Additionally, the moisturizer did not significantly induce nor inhibit the formation of S. aureus biofilm relative to control. Overall, the moisturizer improved the growth ratio of Staphylococcus species, shifting the predominant species from pathogenic S. aureus to commensal S. epidermidis, which may be clinically beneficial in the management of AD. J Drugs Dermatol. 2025;24(4):416-418. doi:10.36849/JDD.8706 .</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"24 4","pages":"416-418"},"PeriodicalIF":1.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of a Moisturizer Containing Colloidal Oatmeal and Filaggrin Technology on Staphylococcus Species In Vitro.\",\"authors\":\"Cleo Whiting, Sara Abdel Azim, Nicolas Joly-Tonetti, Nadege Lachmann, Adam Friedman\",\"doi\":\"10.36849/JDD.8706\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The pathophysiology of atopic dermatitis (AD) is multifactorial, with genetic predisposition, environmental exposures, and dysbiosis of the skin microbiome all associated with disease activity. Colonization by Staphylococcus aureus (S. aureus) is specifically associated with AD, and modifying the skin microbiota through topical skincare products may play a role in AD management. A moisturizer containing colloidal oatmeal, a patented filaggrin technology, niacinamide, and tocopheryl acetate was assessed for its impact on the growth, biofilm formation, and bacterial mix adhesion of S. aureus and/or S. epidermidis on reconstructed human epidermis (RHE). Compared to control conditions, the bacterial growth and adhesion of S. aureus were decreased compared to S. epidermidis in the presence of the moisturizer. Additionally, the moisturizer did not significantly induce nor inhibit the formation of S. aureus biofilm relative to control. Overall, the moisturizer improved the growth ratio of Staphylococcus species, shifting the predominant species from pathogenic S. aureus to commensal S. epidermidis, which may be clinically beneficial in the management of AD. J Drugs Dermatol. 2025;24(4):416-418. doi:10.36849/JDD.8706 .</p>\",\"PeriodicalId\":15566,\"journal\":{\"name\":\"Journal of Drugs in Dermatology\",\"volume\":\"24 4\",\"pages\":\"416-418\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Drugs in Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.36849/JDD.8706\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.8706","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
特应性皮炎(AD)的病理生理学是多因素的,遗传易感性、环境暴露和皮肤微生物群失调都与疾病活动有关。金黄色葡萄球菌(S. aureus)的定植与特应性皮炎特别相关,通过外用护肤品改变皮肤微生物群可能会在特应性皮炎的治疗中发挥作用。研究人员评估了一种含有胶体燕麦片、丝胶专利技术、烟酰胺和生育酚乙酸酯的保湿霜对金黄色葡萄球菌和/或表皮葡萄球菌在重建人体表皮(RHE)上的生长、生物膜形成和细菌混合粘附的影响。与对照组相比,在有保湿剂存在的情况下,金黄色葡萄球菌的生长和附着力均低于表皮葡萄球菌。此外,与对照组相比,保湿剂没有明显诱导或抑制金黄色葡萄球菌生物膜的形成。总之,保湿剂改善了葡萄球菌的生长比例,使主要菌种从致病的金黄色葡萄球菌转变为共生的表皮葡萄球菌,这可能对治疗 AD 有临床益处。J Drugs Dermatol.2025;24(4):416-418. doi:10.36849/JDD.8706 .
Effects of a Moisturizer Containing Colloidal Oatmeal and Filaggrin Technology on Staphylococcus Species In Vitro.
The pathophysiology of atopic dermatitis (AD) is multifactorial, with genetic predisposition, environmental exposures, and dysbiosis of the skin microbiome all associated with disease activity. Colonization by Staphylococcus aureus (S. aureus) is specifically associated with AD, and modifying the skin microbiota through topical skincare products may play a role in AD management. A moisturizer containing colloidal oatmeal, a patented filaggrin technology, niacinamide, and tocopheryl acetate was assessed for its impact on the growth, biofilm formation, and bacterial mix adhesion of S. aureus and/or S. epidermidis on reconstructed human epidermis (RHE). Compared to control conditions, the bacterial growth and adhesion of S. aureus were decreased compared to S. epidermidis in the presence of the moisturizer. Additionally, the moisturizer did not significantly induce nor inhibit the formation of S. aureus biofilm relative to control. Overall, the moisturizer improved the growth ratio of Staphylococcus species, shifting the predominant species from pathogenic S. aureus to commensal S. epidermidis, which may be clinically beneficial in the management of AD. J Drugs Dermatol. 2025;24(4):416-418. doi:10.36849/JDD.8706 .
期刊介绍:
The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.
We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.
Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.